Skip to main content
Premium Trial:

Request an Annual Quote

Bruker AXS IPO Sells 9 Million Shares for $53 Million

NEW YORK, Dec. 14 — X-ray system developer Bruker AXS earned $53 million after filing an initial public offering on Friday that let loose 9 million shares of common stock at a cost of $6.50 apiece, the company announced on Friday. Shares of the Madison, Wis.-based firm began trading on the Nasdaq on Friday under the ticker symbol BAXS, trading at $6.75 just after 11:00 a.m.

 

The company said it plans to use the proceeds for general purposes, including R&D, expanding sales and marketing, strategic acquisitions, general expansion, and debt repayment.

 

The two main underwriters were UBS Warburg and Thomas Weisel Partners. CIBC World Markets, SG Cowen, and Robert W. Baird & Co. were co-managers.

 

Bruker AXS develops and sells advanced systems for crystallography, X-ray diffraction, and X-ray fluorescence. It has development partnerships with GeneFormatics and an equity stake in Integrative Proteomics, and acquired the X-ray crystallography division of Delft Instruments in March. 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.